The non-competitive NMDA receptor antagonist (+)MK-801 counteracts the long-lasting attenuation of the hypothermic response induced by acute doses of 8-OH-DPAT in the rat
- 1 December 1992
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 31 (12) , 1265-1268
- https://doi.org/10.1016/0028-3908(92)90055-t
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Differential inhibition by NMDA antagonists of rapid tolerance to, and cross-tolerance between, ethanol and chlordiazepoxideBrain Research, 1992
- The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the ratBrain Research, 1992
- GABA and Glutamate Receptors as Therapeutic Targets in Neurodegenerative Disorders*Basic & Clinical Pharmacology & Toxicology, 1992
- Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPATNeuropharmacology, 1990
- Preclinical profile of the pyrimidinylpiperazinyl imide compound WY-47,846: A potential anxiolyticDrug Development Research, 1989
- Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletionEuropean Journal of Pharmacology, 1987
- Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the ratNeuropharmacology, 1986
- Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPATJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
- 8-Hydroxy-2-(dipropylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonistJournal of Medicinal Chemistry, 1981